Global Stem Cell Therapy Market is expected to witness tremendous growth owing to the rising prevalence of cancer, heart diseases, stroke, and osteoarthritis. Other key factors such as the change to sedentary lifestyle, growing consumption of alcohol, and an increase in smoking are contributing towards the growth of the market.
Global Stem Cell Therapy Market is expected to reach an approximate CAGR of 10.3% during the forecast period. The use of stem cell for treating medical conditions is referred to as stem cell therapy.
However, factors such as high cost of surgical procedures, expensive chemotherapy treatments, the risk of rejecting cells by patient’s body as the cells are derived from embryos these factors can restrict the market growth during the forecast period.
Some of the key players are Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (US), RTI Surgical, Inc. (US), and AlloSource (US), and Thermo Fisher Scientific Inc
Get Sample for this report at: https://www.marketresearchfuture.com/sample_request/6422
Segmentation
Global Stem Cell Therapy Market, by Technique,
- Primary (Direct) Stem Cell Therapy
- Secondary (Indirect) Stem Cell Therapy
- Salt split technique
- Antigenic mapping method
- Double staining method
- Micro Immunofluorescence
Global Stem Cell Therapy Market, by Product Type
- Antibodies
- Kits and reagents
- Instruments
- Microscopes
- Imaging Analysis Systems
- Labeling dyes
- Species Product Type
Global Stem Cell Therapy Market, by Application
- Clinical research
- Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Neurological Diseases
- Research & Development
Global Stem Cell Therapy Market, by End-User
- Biotechnology Companies
- Hospitals & Research Institutes
- Contract Research Organizations
- Diagnostic centers
Americas is the largest in the market owing to the increasing prevalence of heart diseases and growing healthcare expenditure. According to the Centers for Disease Control and Prevention in November 2017, report every year 735,000 Americans have a heart problem.
Europe (UK, Belgium, France, and Netherlands) is the second largest global stem cell therapy market during the forecast period. The increasing occurrence of stroke, cancer, and osteoarthritis drives the market in this region. According to Anthony Nolan organization 2017, annual review 1.4million people register for donating stem cell in 2017. Also, more than 2,200 searches for a lifesaving stem cell transplant were made in 2017 by UK people. Such a high demand for Stem cell transplantation in this region promotes the market.
Asia-Pacific was projected to be the fastest growing region for the global stem cell therapy market in 2017. The market is expected to witness growth owing to the rising prevalence of smoking in this region.
According to the American Cancer Society, Inc 2018, report China 48.9%, India 16.2%, Japan 11.2% accounts of cancer cases in this region. Such a high cancer rate in this region favors the stem cell therapy market in this region.
The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, the rising oncology and technology both at the hospital level and in the community are expected to influence the market in a positive way.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment